"10.1371_journal.pone.0022062","plos one","2011-07-20T00:00:00Z","Fredrik Nyberg; Atsushi Ogiwara; Chris G Harbron; Takao Kawakami; Keiko Nagasaka; Sachiko Takami; Kazuya Wada; Hsiao-Kun Tu; Makiko Otsuji; Yutaka Kyono; Tae Dobashi; Yasuhiko Komatsu; Makoto Kihara; Shingo Akimoto; Ian S Peers; Marie C South; Tim Higenbottam; Masahiro Fukuoka; Koichiro Nakata; Yuichiro Ohe; Shoji Kudoh; Ib Groth Clausen; Toshihide Nishimura; György Marko-Varga; Harubumi Kato","Global Epidemiology, AstraZeneca R&D, Mölndal, Sweden; Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden; Research and Development Division, Medical ProteoScope Company, Tokyo, Japan; Clinical Proteome Center, Tokyo Medical University, Tokyo, Japan; Discovery Statistics, AstraZeneca R&D, Macclesfield, United Kingdom; AstraZeneca in Respiratory Biological Sciences, AstraZeneca R&D, Lund, Sweden; Department of Medical Oncology, Kinki University School of Medicine, Osaka, Japan; Nakata Clinic, Tokyo, Japan; Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan; Japan Anti-Tuberculosis Association Fukujuji Hospital, Tokyo, Japan; Division of Pulmonary Medicine, Infectious Diseases and Oncology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan; Respiratory Biological Sciences, AstraZeneca R&D, Lund, Sweden; Department of Surgery, Tokyo Medical University, Tokyo, Japan; Niizashiki Central General Hospital, Saitama, Japan","Conceived and designed the experiments: FN AO CGH TK Y. Kyono Y. Komatsu MK SA TH TN MF K. Nakata YO SK GMV HK. Performed the experiments: TK K. Nagasaka ST Y. Kyono TD Y. Komatsu MK. Analyzed the data: FN AO CGH TK ST KW HKT MO Y. Komatsu SA ISP MCS IGC TN GMV. Contributed reagents/materials/analysis tools: AO TK K. Nagasaka ST KW HKT MO Y. Kyono TD Y. Komatsu MK SA MF K. Nakata YO SK HK. Wrote the paper: FN AO CGH TK Y. Komatsu IGC TN GMV. Supervised clinical and epidemiological aspects of the study: FN TH MF K. Nakata YO SK HK. Supervised proteomic aspects of the study: AO TN GMV. Critical review and revision of the manuscript: FN AO CGH TK K. Nagasaka ST KW HKT MO Y. Kyono TD Y. Komatsu MK SA ISP MCS TH MF K. Nakata YO SK IGC TN GMV HK.","FN, CGH, ISP, MCS and IGC are employees of AstraZeneca and own shares in the company. AO, TK, K. Nagasaka, ST, KW, HKT, MO, Y. Kyono, TD, Y. Komatsu, MK, SA, and TN are/were employees of Medical Proteoscope Co., Ltd. TH is an employee of Chiesi Farmaceutici. TH and GMV are previous employees of AstraZeneca. MF has received honoraria from AstraZeneca. K. Nakata, YO, SK, and HK have declared that no conflicts of interest exist.","2011","07","Fredrik Nyberg","FN",25,TRUE,5,2,9,5,TRUE,TRUE,TRUE,5,"11;14;15;16;22",TRUE
